Literature DB >> 2688870

Centromere structure and function in neoplasia.

B K Vig1, K L Sternes, N Paweletz.   

Abstract

The mammalian centromere plays an essential role in maintenance of diploidy in the cell. It is therefore imperative that we understand the structure and function of the mammalian centromere in order to plan strategy to control the incidence of aneuploidy and resultant malformations of the nonneoplastic as well as neoplastic tissues. Even though considerable information is available about the structure and some functional aspects of centromeres of lower eukaryotes such as yeast, the structure of the mammalian centromere is still a matter of conjecture limited to an understanding of the base composition of the alphoid sequences putatively located in the centromeric DNA of higher apes. We do, however, have a better understanding of the structure and role of the kinetochore. In all eukaryotes analyzed so far, the centromeres in a given genome separate in a sequential manner dependent upon the time of replication of pericentric and centromeric DNA. Some chromosomes, generally found in neoplastic cells, that carry more than one centromere show premature separation of the accessory centromeres. These centromeres and the associated pericentric regions replicate their DNA in an earlier part of the S phase than those that show kinetochore activity; both, however, carry DNA of the same composition. The active centromeres in these chromosomes show kinetochore protein binding as detected by antikinetochore antibody; the inactive centromeres are usually devoid of these proteins. The double minutes in neoplastic cells also lack kinetochore proteins, perhaps due to a lack of any centromere. Some dicentric and multicentric chromosomes in cancer cells and transformed cell lines do not display premature centromere separation. In these chromosomes, all centromeric sites show kinetochore proteins and all centromeric regions replicate their DNA simultaneously. These chromosomes also exhibited meiotic-like behavior of some centromeres and show postanaphase separation of some centromeres, resulting in bridges. These bridges, upon breakage and rejoining of sister chromatids, generate new multicentric chromosomes. The resulting chromosomes also exhibit formation of compound kinetochores. Some of these phenomena are novel descriptions of the centromere behavior in cancer cells. This review also discusses the role of aberrant centromere separation in human biology, providing correlates between errors of centromere separation and neoplasia.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2688870     DOI: 10.1016/0165-4608(89)90028-9

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  5 in total

1.  Identification of a high frequency of chromosomal rearrangements in the centromeric regions of prostate cancer cell lines by sequential giemsa banding and spectral karyotyping.

Authors:  B Beheshti; J Karaskova; P C Park; J A Squire; B G Beatty
Journal:  Mol Diagn       Date:  2000-03

2.  Quantitative analysis of centromeric FISH spots during the cell cycle by image cytometry.

Authors:  Genta Amakawa; Kenzo Ikemoto; Hideaki Ito; Tomoko Furuya; Kohsuke Sasaki
Journal:  J Histochem Cytochem       Date:  2013-07-04       Impact factor: 2.479

3.  A cytogenetic study of hospital workers occupationally exposed to radionuclides in Serbia: premature centromere division as novel biomarker of exposure?

Authors:  Jelena Pajic; Boban Rakic; Dubravka Jovicic; Aleksandar Milovanovic
Journal:  Int Arch Occup Environ Health       Date:  2015-09-15       Impact factor: 3.015

4.  Uracil DNA N-glycosylase promotes assembly of human centromere protein A.

Authors:  Samantha G Zeitlin; Brian R Chapados; Norman M Baker; Caroline Tai; Geir Slupphaug; Jean Y J Wang
Journal:  PLoS One       Date:  2011-03-02       Impact factor: 3.240

5.  The Genomic Landscape of Centromeres in Cancers.

Authors:  Anjan K Saha; Mohamad Mourad; Mark H Kaplan; Ilana Chefetz; Sami N Malek; Ronald Buckanovich; David M Markovitz; Rafael Contreras-Galindo
Journal:  Sci Rep       Date:  2019-08-02       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.